We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+11.66%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$115B
AUM Growth
+$4.93B
(+4.5%)
Cap. Flow
-$5.87B
Cap. Flow
% of AUM
-5.12%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,953
New
141
Increased
711
Reduced
931
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$234M |
| 2 |
Gilead Sciences
GILD
|
+$172M |
| 3 |
CVS Health
CVS
|
+$169M |
| 4 |
Public Service Enterprise Group
PEG
|
+$158M |
| 5 |
Bank of America
BAC
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$338M |
| 2 |
JPMorgan Chase
JPM
|
+$288M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$276M |
| 4 |
Medtronic
MDT
|
+$257M |
| 5 |
Advanced Micro Devices
AMD
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Healthcare | 12.6% |
| 3 | Financials | 12.53% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
UBS Group
UBS
$176B
| $7.26M | 0.01% |
234,498
+56,098
| +31% | +$1.48M |
|
827
iShares MSCI Saudi Arabia ETF
KSA
$626M
| $7.19M | 0.01% |
169,951
-54,360
| -24% | -$2.13M |
|
828
Alkermes
ALKS
$8.26B
| $7.19M | 0.01% |
259,238
+58,399
| +29% | +$1.52M |
|
829
Johnson Controls International
JCI
$92.9B
| $7.17M | 0.01% |
124,395
-108,836
| -47% | -$5.71M |
|
830
Option Care Health
OPCH
$3.53B
| $7.15M | 0.01% |
212,086
-36,628
| -15% | -$1.13M |
|
831
MPLX
MPLX
$60.8B
| $7.01M | 0.01% |
190,797
+6,508
| +4% | +$234K |
|
832
Brown & Brown
BRO
$23.8B
| $6.94M | 0.01% |
97,651
-9,526
| -9% | -$681K |
|
833
EPAM Systems
EPAM
$5.62B
| $6.9M | 0.01% |
23,211
-20,745
| -47% | -$5.27M |
|
834
Clear Channel Outdoor Holdings
CCO
$1.23B
| $6.88M | 0.01% |
3,780,660
+131
| +0% | +$181 |
|
835
AGNC Investment
AGNC
$12.7B
| $6.88M | 0.01% |
700,900
-110,758
| -14% | -$973K |
|
836
Sarepta Therapeutics
SRPT
$1.7B
| $6.76M | 0.01% |
70,141
-1,080
| -2% | -$104K |
|
837
Telus
TU
$14.6B
| $6.76M | 0.01% |
378,392
-42,805
| -10% | -$740K |
|
838
iShares Core S&P Small-Cap ETF
IJR
$113B
| $6.7M | 0.01% |
61,932
+38,867
| +169% | +$3.75M |
|
839
Nasdaq
NDAQ
$52.4B
| $6.68M | 0.01% |
114,868
+8,409
| +8% | +$443K |
|
840
Dr. Reddy's Laboratories
RDY
$10.1B
| $6.67M | 0.01% |
479,250
+97,485
| +26% | +$1.3M |
|
841
Rentokil
RTO
$12.6B
| $6.61M | 0.01% |
230,867
+212,927
| +1,187% | +$6.25M |
|
842
Cboe Global Markets
CBOE
$30.2B
| $6.58M | 0.01% |
36,864
+3,344
| +10% | +$573K |
|
843
iShares MSCI EAFE Growth ETF
EFG
$17B
| $6.58M | 0.01% |
+67,961
| New | +$6.09M |
|
844
Bloomin' Brands
BLMN
$765M
| $6.58M | 0.01% |
+233,681
| New | +$5.68M |
|
845
Omnicom Group
OMC
$21.9B
| $6.58M | 0.01% |
76,024
-19,943
| -21% | -$1.57M |
|
846
Target
TGT
$67.9B
| $6.55M | 0.01% |
46,015
-3,154
| -6% | -$385K |
|
847
Lloyds Banking Group
LYG
$91.3B
| $6.55M | 0.01% |
2,732,656
+37,212
| +1% | +$79.7K |
|
848
Dover
DOV
$28.2B
| $6.53M | 0.01% |
42,469
-10,661
| -20% | -$1.49M |
|
849
Prudential Financial
PRU
$42.8B
| $6.53M | 0.01% |
62,934
-1,827
| -3% | -$175K |
|
850
Halozyme
HALO
$9.89B
| $6.52M | 0.01% |
176,456
-7,997
| -4% | -$301K |
|
Similar funds
Neuberger Berman Group's Q4 2023 Portfolio in Review
As of Q4 2023, Neuberger Berman Group held 1,953 positions worth $115B, up 4.5% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Neuberger Berman Group withdrew a net $5.87B in Q4 2023, closing 90 positions and reducing 931 holdings. Its most notable exit was Activision Blizzard, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Neuberger Berman Group opened a new position in Avantis Emerging Markets Equity ETF worth $27.4M.
- Neuberger Berman Group's largest Q4 2023 buy was Avantis Emerging Markets Equity ETF: 486,139 shares worth $27.4M.
- Neuberger Berman Group added most to UnitedHealth in Q4 2023, an estimated $234M increase.
- Neuberger Berman Group's biggest Q4 2023 reduction was Chevron, cutting an estimated $338M.
- Neuberger Berman Group fully exited Activision Blizzard in Q4 2023, selling an estimated $276M.
- Neuberger Berman Group's ten largest holdings make up 17% of its $115B portfolio in Q4 2023.
- Neuberger Berman Group opened 141 new positions and closed 90 in Q4 2023.
- Neuberger Berman Group's portfolio value rose 4.5% quarter-over-quarter to $115B.
Based on Neuberger Berman Group's 13F filing for Q4 2023, filed 9 Feb 2024.